Sale of Strategy and Marketing Company
Advised the shareholders of an internationally renowned boutique loyalty strategy and marketing company on its sale to a NASDAQ-listed global consulting and digital services provider.
Sale of Air Conditioning Equipment Distributor
Advised the shareholders of one of the largest U.K. air conditioning equipment distributors on their sale to a global electronics technology and solutions company.
Acquisitions of Global Financial Advisory, Asset Management Firm
Advised a New York-based a global investment and advisory financial services firm in connection with its acquisition of another global financial advisory and asset management firm.
Series A Fintech Investment
Advised a private equity firm in relation to a multimillion-pound Series A investment into a fintech payments company.
Sale of Health Care Communications Agency
Advised the shareholders of a specialist health care communications agency in their sale to a FTSE 250 health care advisory, communications, commercial, clinical and packaging services company.
Sale of KOL/HCP Marketing Agency
Advised the shareholders of a key opinion leader/health care provider (KOL/HCP) marketing agency in their sale to a subsidiary of a publicly traded FTSE 100 global marketing agency.
Sake of Life Science Intermediary
Advised the shareholders of the largest provider of IVF programmes in the U.K. on their sale to a private equity buyer.
Advised Biopharma Company on Strategic Investment
Advised a biopharmaceutical company focused on developing new, cost-effective and proprietary treatment options for patients, on its strategic investment into a Scottish-based clinical stage biopharmaceutical company developing novel oxygen carriers and software for use with MRI.
Advised Shareholders on Sale to Private Equity Buyer
Advised the shareholders of an HVAC designer and installer on its sale to a capital investment group.
Advised U.K. Food Service Company on Sale
Advised U.K. food service company on the sale of its business and assets to a subsidiary of an NYSE-listed corporation.
Sale of Health Care Analytics Service Provider to FTSE-listed Company
Advised the shareholders of a health care analytics service provider on the sale of a 75% stake in the company to a FTSE-listed creative transformation company.